News
Patients with challenging diabetic macular edema may achieve anatomical gains and extended dosing intervals with bispecific faricimab.
Cabozantinib is a vascular endothelial growth factor receptor tyrosine kinase inhibitor, a drug used as a therapy for several ...
Corneal crosslinking (CXL) can be used to treat corneal neovascularization (CNV) if any causative infection is eradicated at the time of treatment or shortly thereafter, according to research ...
Aurion will operate as a separate company with full support from Alcon to advance its clinical-stage allogeneic cell therapy asset, AURN001, into Phase 3 for corneal edema secondary to corneal ...
Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Corneal Edema - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. A comprehensive report has been released ...
Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Corneal Edema - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. A comprehensive report has been released ...
SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Dec 18, 2024-- ...
an allogeneic cell therapy product candidate for the treatment of corneal edema secondary to corneal endothelial dysfunction. AURN001 is a combination cell therapy product candidate comprised of ...
Corneal edema, also called corneal swelling, is a buildup of fluid in your cornea, the clear lens that helps focus light onto the back of your eye. One common cause of corneal edema is a problem ...
EO2002 was studied in EMME-001 as a treatment for corneal edema without the need for invasive and high-risk surgical procedures, such as corneal transplantation or endothelial scraping.
The irreversible corneal edema or swelling starts with endothelial damage, followed by gradual stromal and epithelial edema. The formation of bullae or blister-like lesions occurs when the ...
The corneal edema market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of corneal edema in the US is expected to increase, driven by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results